Carl Zuelke

4.6k total citations · 2 hit papers
14 papers, 3.4k citations indexed

About

Carl Zuelke is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, Carl Zuelke has authored 14 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Epidemiology and 4 papers in Hepatology. Recurrent topics in Carl Zuelke's work include Organ Transplantation Techniques and Outcomes (5 papers), Liver Disease and Transplantation (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Carl Zuelke is often cited by papers focused on Organ Transplantation Techniques and Outcomes (5 papers), Liver Disease and Transplantation (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Carl Zuelke collaborates with scholars based in Germany and Czechia. Carl Zuelke's co-authors include Edward K. Geissler, Gudrun E. Koehl, Karl‐Walter Jauch, Matthias Anthuber, Philipp von Breitenbuch, Matthias Hornung, Markus Guba, Christiane J. Bruns, Stefan Farkas and Markus Steinbauer and has published in prestigious journals such as JAMA, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Carl Zuelke

14 papers receiving 3.3k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

2007 1.8k citations Helmut Oettle, Stefan Post et al. JAMA profile →
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

2002 1.4k citations Markus Guba, Philipp von Breitenbuch et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carl Zuelke Germany	9	2.2k	1.1k	889	881	807	14	3.4k
David G. Heidt United States	15	2.4k 1.1×	624 0.6×	1.8k 2.0×	213 0.2×	291 0.4×	22	3.7k
Sven Arke Lang Germany	25	1.2k 0.5×	1.4k 1.2×	469 0.5×	586 0.7×	463 0.6×	112	2.9k
Peter Langmuir United States	30	1.8k 0.8×	320 0.3×	1.3k 1.5×	438 0.5×	1.6k 2.0×	56	4.7k
David F. Schaeffer Canada	34	1.5k 0.7×	825 0.7×	980 1.1×	582 0.7×	602 0.7×	144	3.2k
Hiroyoshi Ayabe Japan	28	802 0.4×	1.1k 1.0×	680 0.8×	148 0.2×	1.1k 1.3×	205	2.6k
Benjamin Esterni France	32	2.2k 1.0×	512 0.5×	1.4k 1.6×	283 0.3×	683 0.8×	75	4.4k
Shinichi Aishima Japan	40	2.2k 1.0×	2.1k 1.9×	990 1.1×	1.5k 1.7×	912 1.1×	167	5.1k
Hans‐Detlev Saeger Germany	27	2.4k 1.1×	1.8k 1.6×	670 0.8×	612 0.7×	811 1.0×	112	3.5k
Andrew H. Ko United States	35	3.8k 1.7×	769 0.7×	1.4k 1.6×	626 0.7×	963 1.2×	150	4.9k
Motoki Yano Japan	34	1.2k 0.6×	622 0.5×	1.1k 1.3×	403 0.5×	2.0k 2.5×	170	3.7k

Countries citing papers authored by Carl Zuelke

Since Specialization

Citations

This map shows the geographic impact of Carl Zuelke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Zuelke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Zuelke more than expected).

Fields of papers citing papers by Carl Zuelke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Zuelke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Zuelke. The network helps show where Carl Zuelke may publish in the future.

Co-authorship network of co-authors of Carl Zuelke

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Zuelke. A scholar is included among the top collaborators of Carl Zuelke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Zuelke. Carl Zuelke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Lamby, P., et al.. (2009). Procedures for ethical review for clinical trials within the EU. BMJ. 338(may22 1). b1893–b1893. 4 indexed citations

Doenecke, Axel, et al.. (2009). Pre‐existent portal vein thrombosis in liver transplantation: influence of pre‐operative disease severity. Clinical Transplantation. 24(1). 48–55. 37 indexed citations

Geissler, Edward K., Andreas A. Schnitzbauer, Carl Zuelke, et al.. (2008). THE SILVER STUDY: AN INVESTIGATOR-INITIATED TRIAL TO DETERMINE IF SIROLIMUS USE CAN IMPROVE HCC RECURRENCE-FREE SURVIVAL IN AFFECTED LIVER TRANSPLANT RECIPIENTS. Transplantation. 86(2S). 679–680. 2 indexed citations

Neuhaus, P., Hanno Riess, Stefan Post, et al.. (2008). CONKO-001: Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC). Journal of Clinical Oncology. 26(15_suppl). LBA4504–LBA4504. 100 indexed citations

Oettle, Helmut, Stefan Post, P. Neuhaus, et al.. (2007). Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer. JAMA. 297(3). 267–267. 1754 indexed citations breakdown →

Koehl, Gudrun E., Andreas Gäumann, Carl Zuelke, et al.. (2006). Development of De Novo Cancer in p53 Knock-Out Mice is Dependent on the Type of Long-Term Immunosuppression Used. Transplantation. 82(6). 741–748. 16 indexed citations

Farkas, Stefan, Ulrich Bolder, Aiman Obed, et al.. (2005). Conditioning of liver grafts with prostaglandins improves bile acid transport. Transplantation Proceedings. 37(1). 435–438. 1 indexed citations

Ploner, Franz, et al.. (2005). Plasma disappearance of indocyanine green: a marker for excretory liver function?. Intensive Care Medicine. 31(12). 1719–1722. 48 indexed citations

Mandraka, Falitsa, Carl Zuelke, & G. Lock. (2003). [Cholestasis and vomiting: unusual differential diagnosis in a case of Peutz-Jeghers syndrome].. DMW - Deutsche Medizinische Wochenschrift. 128(18). 984–8. 1 indexed citations

10.

Graeb, Christian, Marcus N. Scherer, Joachim Andrassy, et al.. (2002). Use of an adenoviral vector to express soluble donor-major histocompatibility complex molecules capable of suppressing the immune response in rat transplant recipients. Human Immunology. 63(10). 844–852. 12 indexed citations

11.

Guba, Markus, Philipp von Breitenbuch, Markus Steinbauer, et al.. (2002). Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nature Medicine. 8(2). 128–135. 1378 indexed citations breakdown →

12.

Jauch, K.‐W., et al.. (2001). Therapiestrategien beim Lebertrauma. 36(5). 310–317. 1 indexed citations

13.

Anthuber, Matthias, Carl Zuelke, H. Forst, et al.. (1993). Experiences with a simplified liver harvesting technique--single aorta in situ flush followed by portal back table flush.. PubMed. 25(6). 3154–5. 8 indexed citations

14.

Anthuber, M, E. Pratschke, Jauch Kw, et al.. (1992). Liver retransplantation--indications, frequency, results.. PubMed. 24(5). 1965–6. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact